20187-55-7 | 2-[(1-benzyl-1H-indazol-3-yl)oxy]acetic acid

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$25.00	$17.00
5g	98%	in stock	$49.00	$34.00
25g	98%	in stock	$105.00	$74.00
100g	98%	in stock	$297.00	$208.00
500g	98%	in stock	$1,069.00	$748.00

Description

• Catalog Number: AB03362
• Chemical Name: 2-[(1-benzyl-1H-indazol-3-yl)oxy]acetic acid
• CAS Number: 20187-55-7
• Molecular Formula: C16H14N2O3
• Molecular Weight: 282.29396
• MDL Number: MFCD00866158
• SMILES: OC(=O)COc1nn(c2c1cccc2)Cc1ccccc1

Computed Properties

• Complexity: 357
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 21
• Hydrogen Bond Acceptor Count: 4
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 5
• XLogP3: 3.1

Literature

• Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models.

  Toxicology and applied pharmacology 20170301

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Synthesis and biological evaluations of novel bendazac lysine analogues as potent anticataract agents.

  Bioorganic & medicinal chemistry letters 20100401

• Gene expression profiling in rat liver treated with compounds inducing elevation of bilirubin.

  Human & experimental toxicology 20090401

• Advances in pharmacological strategies for the prevention of cataract development.

  Indian journal of ophthalmology 20090101

• Topical ocular delivery of NSAIDs.

  The AAPS journal 20080601

• Medical treatment of cataract.

  Clinical & experimental ophthalmology 20070101

• Bendazac lysine inhibition of human lens epithelial cell adhesion to polymethylmethacrylate intraocular lenses.

  Ophthalmic research 20040101

• Antidenaturant drugs for cataract and other condensation diseases.

  Medical hypotheses 20010101